Intracranial News
-
Showcase
succeSRS Dosimetry Audit Service
RTsafe launches the Dosimetry Audit Service – succeSRS The complex nature of the stereotactic treatment process demands commitment to the highest levels of accuracy and precision. That being the case we are thrilled to announce the launch of our new dosimetry audit service aiming to promote a culture of excellence. succeSRS is a powerful tool for quality improvement in intracranial ...
By RTsafe
-
Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients
Intermountain Primary Children’s Hospital First in the Country to Implant this Next Generation FDA-Cleared Device Company Welcomes Vice President of Sales & Marketing, Mark Geiger, Who Lives with Hydrocephalus Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid ...
-
Bayer driving innovation in radiology with new research across the portfolio presented at ECR
Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI Further research explores potential of AI and digital advances in medical imaging Bayer announced today that new data from the company’s advanced radiology portfolio will be presented at the 2023 European Congress of Radiology (ECR), taking place from March 1-5 in Vienna, Austria. The ...
By Bayer AG
-
Aurora BioPharma to Attend Pioneers 2017 at the Mandarin Oriental Hotel in New York
Aurora BioPharma, Inc., a clinical stage biotechnology company developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert Brooks, will attend Pioneers 2017 presented by Joseph Gunnar & Co., LLC taking place Tuesday May 2nd at the Mandarin Oriental Hotel in New York. About Joseph Gunnar & Co., LLC Joseph Gunnar & Co., LLC was founded in 1997 ...
-
Aurora BioPharma To Join In On A Presentation And Discussion On The GBM AGILE Trial At The Ritz-Carlton, Pentagon City
Aurora BioPharma, Inc., a clinical stage biotechnology company developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert Brooks, will join in on a presentation and discussion of the GBM AGILE (Adaptive, Global, Innovative, Learning Environment) trial. The meeting is being held at the Ritz Carlton, at Fashion Centre at Pentagon City, April 11th. About ...
-
An Overview of Glioblastoma
It is estimated that more than 240,000 cases of brain and nervous system tumors are diagnosed each year around the world. The most common and most lethal of these cancerous tumors are glioblastoma (GBM). What is Glioblastoma? Glioblastoma is a type of glioma, which is a brain tumor that begins in the star-shaped glial cells that surround and support nerve cells in the brain. GBM is a Grade IV ...
-
Sense Neuro Diagnostics Participates in Mayo Clinic and ASU MedTech Accelerator
CINCINNATI, OH – March 30, 2022 – Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, has been selected to participate in the Mayo Clinic and Arizona State University MedTech Accelerator. The flagship program of the Mayo Clinic and ASU Alliance for Health Care was designed to provide early-stage medical device and ...
-
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announces its operating results for the first quarter of fiscal year 2022 ended December 31, 2021. First Quarter and Recent Business Updates Submitted clearance ...
-
Aidoc Showcases Full Ai Care Coordination Suite At International Stroke Conference 2022
AI-powered neuroscience solutions for intracranial hemorrhage, ischemic stroke, cervical spine fractures, on display at ISC 2022, New Orleans, February 9-11, Booth #801 New York, February 8, 2022 – Aidoc, the leading provider of healthcare AI solutions, will be delivering a live demonstration of its comprehensive AI care coordination suite at ISC 2022, February 9-11, in New Orleans, Booth ...
By Aidoc
-
Aidoc Partners With Novant Health, Providing Imaging Ai To Expedite Treatment For Patients In The Emergency Department
Novant Health’s integration of Aidoc’s AI solutions, amid the latest wave of the Omicron variant, expands upon its existing slate of innovative technologies designed to improve delivery of patient care and outcomes Aidoc, the leading provider of enterprise-grade AI solutions for medical imaging, announces a partnership with Novant Health, a health network of over 1,800 physicians ...
By Aidoc
-
GammaTile Therapy Delivers Targeted Radiation to Cancer Cells
Drs. Ondrej Choutka, MD, a neurosurgeon, and Lindsay Sales, MD, a radiation oncologist at Saint Alphonsus Regional Medical Center in Boise, have become the first doctors in the Pacific Northwest to utilize a new treatment for brain tumors. They implanted the FDA-cleared GammaTile therapy in a 44-year-old patient with a malignant brain tumor. The current standard of care for patients with ...
-
Another good news for Deep01! Taiwan`s first AI product obtained marketing approval from Japan`s FDA
DeepCT - Intracranial Hemorrhage (ICH) AI Detection Software - developed by Taiwan's high-profile AI start-up team Deep01 - has obtained the marketing approval of Japan's PMDA, which is the first deep learning software officially licensed by Japan in Taiwan , marking a new milestone in Taiwan's AI medical output. Japan has the world's most aging population, and with advanced medical development, ...
-
Aidoc Releases The First ‘Ai Os’ Unifying Ai Across Enterprise Imaging To Address Technical Barriers Of Using Ai
Health networks can now continuously expand their AI stack without overhauling their IT infrastructure with each new tool Aidoc, a leading provider of artificial intelligence (AI) solutions for medical imaging, announces today the release of the first AI Operating System (OS) allowing for the clinical use of numerous AI applications over one unified system. To complement its new OS, ...
By Aidoc
-
Aidoc And Screenpoint Medical Announce Partnership To Provide Complete Ai Solution For Breast Imaging
Aidoc’s comprehensive AI continues to expand to cover the majority of radiology adult subspecialties Aidoc, the leading provider of AI for medical imaging, and ScreenPoint Medical, leader of deep learning AI for 2D and 3D mammography, today announced a collaboration which will incorporate ScreenPoint’s capabilities into Aidoc’s platform. Breast imaging specialists will now be ...
By Aidoc
-
Aidoc And Riverain Technologies Partner To Streamline Access To Time Saving Chest Ai Solutions
Partnership provides a seamless workflow to improve patient outcomes while enabling radiologists to read faster with commercially available solutions. Aidoc and Riverain Technologies, two leading providers of AI for medical imaging, announced a new collaboration today. This new partnership will improve provider access to both solutions by incorporating Riverain’s commercially available ...
By Aidoc
-
Imperative Care Announces First Patient Enrolled in the Imperative Trial Evaluating the Zoom 88 Large Distal Platform for the Treatment of Ischemic Stroke
Imperative Care, Inc. announced today that the first patient has been enrolled in the Imperative Trial. This prospective, multi-center clinical trial is the first study designed to evaluate the clinical benefits of direct aspiration for the treatment of ischemic stroke with the Zoom 88 Large Distal Platform, which is currently FDA cleared for neurovascular access. Additionally, the trial will ...
-
DeepCT - world-leading AI-powered triage system on head CT images - will be showed in RSNA
Deep01's partner - MedicalAI Solutions - will demo DeepCT in 2021 RSNA. We are excited to show our latest development of AI solutions in this big event. DeepCT is the world-leading AI-powered triage system on head CT images. It identifies intracranial hemorrhage(ICH) and provides related analysis which empowers physicians for better and faster decisions. Please mail to service@deep01.com to ...
-
Sense receives clearance to expand ongoing clinical trial to evaluate non-invasive brain scanner to sites in India and Canada
Clinical trial underway at five US hospital sites to evaluate Sense’s novel, non-invasive brain scanner to monitor intracranial hemorrhage in acute hospital setting Drug Controller General of India (DCGI) and Health Canada grant permission to conduct clinical trial at multiple sites in India and Canada Current standard of care lacks a means to monitor brain injury continuously, ...
-
GT Medical Technologies Presents Clinical Data on GammaTile® Therapy for Brain Tumors at the 2021 American Association of Neurological Surgeons Scientific Virtual Meeting
GT Medical Technologies, Inc. today announced it is presenting clinical data in two oral presentations on the company's breakthrough GammaTile® Therapy for patients with brain tumors at the 2021 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting. The presenting authors, Dr. David Brachman, co-founder and CTO at GT Medical Technologies and Dr. Mehee Choi, director ...
-
Balt Completes Enrollment in FIRST: A Multi-center, Prospective, International Study of Low Profile Silk Vista Flow Diverters
Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today announced enrollment in the FIRST study has been completed. The FIRST study is an observational, prospective, multi-center, international, single-arm study with the aim of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you